Crossmark

Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial

Crossref DOI link: https://doi.org/10.1007/s00540-020-02788-6

Published Online: 2020-05-16

Published Print: 2020-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Doi, Matsuyuki http://orcid.org/0000-0002-8574-8776
Morita, Kiyoshi

Takeda, Junzo

Sakamoto, Atsuhiro

Yamakage, Michiaki

Suzuki, Toshiyasu
License Information

Text and Data Mining valid from 2020-05-16

Version of Record valid from 2020-05-16
More Information

Article History

Received: 18 November 2019

Accepted: 2 May 2020

First Online: 16 May 2020

Compliance with ethical standards

:

: M. Doi is a consultant of PAION UK and Mundipharma. All others authors have no interests to declare.

Document is current

Any future updates will be listed below